TELA Bio, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TELA Bio, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $0.00.
- TELA Bio, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $27.00K, a 55.00% decline year-over-year.
- TELA Bio, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $0.00.
- TELA Bio, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $45.00K, a 61.54% decline year-over-year.
- TELA Bio, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $105.00K, a 62.63% decline from fiscal 2024.
- TELA Bio, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $281.00K, a 219.32% increase from fiscal 2023.
- TELA Bio, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $88.00K, a 76.00% increase from fiscal 2022.
- TELA Bio, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $50.00K, a 31.58% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $72.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $27.00K 10-Q · filed 2026-05-13 | $72.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $105.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $45.00K 10-Q · filed 2025-11-14 | $105.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $177.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $60.00K 10-Q · filed 2026-05-13 | $177.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $281.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $117.00K 10-Q · filed 2025-11-14 | $281.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $252.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $164.00K 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $88.00K 10-K · filed 2026-03-25 |
| 2023-09-30 | $88.00K 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $50.00K 10-K · filed 2025-03-21 | |
| 2021-12-31 | $38.00K 10-K · filed 2024-03-22 | |
| 2020-12-31 | $34.00K 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |